Skip to content

Shanghai Pharmaceuticals

Request correction

A leading Chinese pharmaceutical company in R&D, manufacturing, and distribution.

Last updated October 9, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
2
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Shanghai Pharmaceuticals is a leading Chinese pharmaceutical company covering R&D, manufacturing, distribution, and retail, with products including chemical drugs, biologics, and traditional Chinese medicine.

Products and positioning

One of the leading enterprises in China's pharmaceutical industry.

Product categories. chemical drugs · biologics · traditional Chinese medicine · pharmaceutical distribution services

Controversies

  • 2023

    Subsidiary fined and disgorged a total of about RMB 462 million for unfair high-price drug sales

    In 2023, the Shanghai Municipal Administration for Market Regulation found that Shanghai Pharmaceuticals subsidiary Shanghai No. 1 Biochemical & Pharmaceutical Co. abused its dominant market position by selling polymyxin B sulfate for injection at unfairly high prices. It confiscated about RMB 338 million in illegal gains and imposed a fine of about RMB 124 million. The liable party was that subsidiary and the specified drug.

Read more

Recent events

  • Reported

    Shanghai Pharmaceuticals and CanSino Biologics sign strategic cooperation agreement[2]

    Shanghai Pharmaceuticals and CanSino Biologics signed a strategic cooperation agreement covering vaccine research and development, production and capacity expansion, materials reserves, and supply-chain development. The agreement also provides for nationwide vaccine storage, distribution, and supply-chain services.

Read more

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/shanghai-pharmaceuticals · Editorial policy · How profiles are compiled